We are live on ! Find out more
IGC icon

IGC Pharma
IGC

4 hedge funds and large institutions have $108K invested in IGC Pharma in 2018 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed

80% less funds holding

Funds holding: 20 → 4 (-16)

89% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 18

96% less capital invested

Capital invested by funds: $3.07M → $108K (-$2.96M)

Holders
4
Holders Change
-16
Holders Change %
-80%
% of All Funds
0.09%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
1
Reduced
–
Closed
18
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
DP
Dearborn Partners
Illinois
+$476K
2
CFA
Carroll Financial Associates
North Carolina
+$5.11K
3
Simplex Trading
Simplex Trading
Illinois
+$1.02K

Top Sellers

Rank Fund Capital Flow
1
Creative Planning
Creative Planning
Kansas
-$420K
2
HSBC Holdings
HSBC Holdings
United Kingdom
-$385K
3
SB
Suntrust Banks
Georgia
-$355K
4
Jane Street
Jane Street
New York
-$137K
5
IG
ING Group
Netherlands
-$97K
Name Holding Trade Value Shares
Change 		Change in
Stake
CFA
1
Carroll Financial Associates
North Carolina
$82K +$5.11K +1,000 +0.5%
DP
2
Dearborn Partners
Illinois
$26K +$476K +93,175 New
Creative Planning
3
Creative Planning
Kansas
– -$420K -65,049 Closed
HSBC Holdings
4
HSBC Holdings
United Kingdom
– -$385K -59,730 Closed
SB
5
Suntrust Banks
Georgia
– -$355K -55,000 Closed
Jane Street
6
Jane Street
New York
– -$137K -21,309 Closed
IG
7
ING Group
Netherlands
– -$97K -15,000 Closed
Cambridge Investment Research Advisors
8
Cambridge Investment Research Advisors
Iowa
– -$75K -11,700 Closed
LTFS
9
Ladenburg Thalmann Financial Services
Florida
– -$63K -8,375 Closed
AG
10
Advisor Group
Arizona
– -$33K -5,232 Closed
Citigroup
11
Citigroup
New York
– -$19K -3,000 Closed
UBS Group
12
UBS Group
Switzerland
– -$19K -2,991 Closed
Royal Bank of Canada
13
Royal Bank of Canada
Ontario, Canada
– -$11K -1,670 Closed
PA
14
Parallel Advisors
California
– -$11K -1,655 Closed
FANJ
15
Financial Architects (New Jersey)
New Jersey
– -$6K -1,000 Closed
OIA
16
Optimum Investment Advisors
Illinois
– -$6K -1,000 Closed
Morgan Stanley
17
Morgan Stanley
New York
– -$5K -725 Closed
ASN
18
Advisory Services Network
Georgia
– -$5K -700 Closed
Bank of America
19
Bank of America
North Carolina
– -$3K -500 Closed
Deutsche Bank
20
Deutsche Bank
Germany
– -$1K -100 Closed
Simplex Trading
21
Simplex Trading
Illinois
– +$1.02K +200 New

IGC Hedge Fund Activity: Q4 2018 in Review

4 of the 4,488 institutional investors tracked by Wall St. Rank reported a position in IGC Pharma (IGC) for Q4 2018, worth a combined $108K — down 96% from $3.07M a quarter earlier.

Sellers outnumbered buyers: 18 funds closed out of IGC and 2 opened new positions — a net loss of 16 holders — while 0 trimmed existing stakes and 1 added.

The largest buyer was Dearborn Partners, opening a new position worth an estimated $476K. The largest seller was Creative Planning, exiting entirely with an estimated $420K sold.

  • 4 institutional investors held IGC Pharma (IGC) as of Q4 2018, down from 20 in Q3 2018.
  • Funds reported $108K of IGC Pharma stock for Q4 2018, down 96% quarter-over-quarter.
  • 2 funds opened new IGC Pharma positions in Q4 2018 and 18 closed out, a net change of -16 holders.
  • The largest IGC Pharma buyer in Q4 2018 was Dearborn Partners, an estimated $476K added.
  • The largest IGC Pharma seller in Q4 2018 was Creative Planning, an estimated $420K sold.

Based on aggregated 13F filings for Q4 2018.